InvestorsHub Logo
Followers 65
Posts 2382
Boards Moderated 0
Alias Born 01/16/2011

Re: ADVFN_curncman post# 27467

Saturday, 08/15/2020 12:30:08 PM

Saturday, August 15, 2020 12:30:08 PM

Post# of 64546
New study: Vascular disease? Not a respiratory illness?

... drowned within the lungs? Not taking issue with you, but waaay more to learn about the debilitating effects of COVID-19.

In a study released by Indiana University School of Medicine this August, in partnership with COVID-19 nonprofit Survivor Corps, long haulers describe nearly 100 side effects, from fatigue and body aches to night sweats and neuropathy.

The study casts doubt on the idea that the COVID-19 is a respiratory illness that lasts only a few weeks, suggesting instead that it may be a vascular disease capable of wreaking havoc on the eyes, skin, heart and brain, long after the sore throat goes away. While some hospitals, such as Mount Sinai in New York, have launched recovery centers for post-COVID care, the Centers for Disease Control and Prevention has released little data on the longterm prognosis for those who survive.

TSOI long

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News